News
 

Researchers at Queen Mary University of London have developed a new method for predicting dementia with over 80% accuracy, up to nine years before diagnosis. This method surpasses traditional memory tests and brain shrinkage measurements. Led by Professor Charles Marshall, the team used functional MRI (fMRI) scans to analyze changes in the brain's...

Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system, commonly diagnosed in individuals aged 20 to 40. It leads to cognitive and physical impairments, including coordination issues, paralysis, sensory disturbances, and vision problems. MS is classified into subtypes like clinically isolated syndrome,...

A new study finds that urolithin A, a substance found in pomegranates, can improve memory and may help treat Alzheimer's disease. This natural compound works by removing damaged mitochondria from the brain, similar to the effects of NAD supplements. While dosage is still being determined, this discovery offers promising potential for treating and...

New drug in MS

05/06/2024

A second-generation anti-CD40L monoclonal antibody has shown remarkable efficacy in reducing multiple sclerosis (MS) disease activity, according to new trial data. This treatment nearly eliminated new brain lesions on MRI scans at 48 weeks for patients receiving the highest dose, without increasing the risk of infections or thrombotic events.

Extreme temperatures are linked to increased stroke mortality, disproportionately affecting low-income regions, according to a new multinational study involving nearly 6 million strokes. The research revealed that out of every 1000 ischemic or hemorrhagic stroke deaths, around 11 were due to extreme hot and cold days.

Previous research has shown that regular caffeine intake is associated with a reduced risk of developing Parkinson's disease. However, the effects of caffeine on disease progression in patients already diagnosed with Parkinson's have not been extensively studied.

Alzheimer's disease is characterized by the accumulation of amyloid plaques in the brain, a hallmark that has been notoriously difficult to address. In a groundbreaking study, researchers have focused on manipulating the plexin-B1 protein to enhance the brain's ability to clear these plaques, offering new hope in the fight against this debilitating...

Sleep apnea events during REM sleep are linked to verbal memory impairment in older adults at risk for Alzheimer's disease. A new research highlights the importance of focusing on sleep-stage-specific apnea severity for accurate diagnosis and treatment.